| S7209 |
GSK650394
|
GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor with IC50 of 62 nM and 103 nM for SGK1 and SGK2, respectively.
|
-
J Clin Invest, 2023, 133(20)e169234
-
J Leukoc Biol, 2023, qiad025
-
Reprod Biol Endocrinol, 2023, 21(1):50
|
|
| S8824 |
EMD638683
|
EMD638683 is a highly selective inhibitor of serum- and glucocorticoid-inducible kinase 1 (SGK1) with IC50 of 3 μM. This compound exhibits antihypertensive potency and anti-tumor activity.
|
-
Gastroenterology Report, 2025, goaf022
-
Gastroenterol Rep (Oxf), 2025, 13:goaf022
-
Stroke and Vascular Neurology, 2023, 453-462
|
|
| S9672 |
PROTAC SGK3 degrader-1
|
PROTAC SGK3 degrader-1 (SGK3-PROTAC1) is a PROTAC conjugate of the 308-R SGK inhibitor with the VH032 VHL binding ligand, targeting SGK3 (Serum/Glucocorticoid Regulated Kinase Family Member 3) for degradation.
|
-
Front Pharmacol, 2023, 14:1169054
|
|
| E7852 |
CKI-7
|
CKI-7 (CKI-7 2HCl) is an inhibitor of casein kinase 1 (CK1) with ki of 8.5 μM and IC50 of 6 μM. It is selective for CK1 over CK2, PKC, CaM kinase II (CaMKII), and cyclic AMP-dependent protein kinase (PKA) with IC50 of 90, >1000, 195, and 550 μM, respectively. This compound also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1).
|
|
|